CompletedNCT01644747
Brain Stimulation Added to Medication for Resistant Depression
About this title
Read the official source — NCT01644747Device studyAges 18–65FranceBipolarity
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Besançon and 5 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: July 19, 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 87
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- France
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01644747
- Official title
Show the full official title
tDCS as an add-on Treatment for Resistant Major Depression in Uni- or Bipolar Patients: a Randomized, Double-blind, Placebo Controlled Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedBesançon · Grenoble · Lyon
3 more locations
- Rennes
- Strasbourg
- Ville Evrard
Questions about this study
Who is behind this study?
The study sponsor is Centre Hospitalier Universitaire de Besancon.
Who was this study for?
Listed age limits: 18 years to 65 years.
Want to explore more studies?
Explore studiesRelated studies
Deep-Brain Stimulation for Chronic Treatment-Resistant Depression
A 24-Week, Flexible-Dose, Open-label Extension Study of Lurasidone for the Treatment of Bipolar I Depression